76 related articles for article (PubMed ID: 1944245)
1. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
Chae K; Gibson MK; Korach KS
Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245
[TBL] [Abstract][Full Text] [Related]
2. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site.
Korach KS; Chae K; Levy LA; Duax WL; Sarver PJ
J Biol Chem; 1989 Apr; 264(10):5642-7. PubMed ID: 2925625
[TBL] [Abstract][Full Text] [Related]
3. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
Metzger DA; Curtis S; Korach KS
Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
[TBL] [Abstract][Full Text] [Related]
4. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites.
Chae K; Johnston SH; Korach KS
J Steroid Biochem Mol Biol; 1991 Jan; 38(1):35-42. PubMed ID: 1997122
[TBL] [Abstract][Full Text] [Related]
5. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor stereochemistry: receptor binding and hormonal responses.
Korach KS; Levy LA; Sarver PJ
J Steroid Biochem; 1987; 27(1-3):281-90. PubMed ID: 3695485
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation.
Kohno H; Bocchinfuso WP; Gandini O; Curtis SW; Korach KS
J Mol Endocrinol; 1996 Jun; 16(3):277-85. PubMed ID: 8782086
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
9. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness.
Korach KS; Chae K; Gibson M; Curtis S
Steroids; 1991 May; 56(5):263-70. PubMed ID: 1877066
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol.
Sato T; Ohta Y; Okamura H; Hayashi S; Iguchi T
Anat Rec; 1996 Mar; 244(3):374-85. PubMed ID: 8742702
[TBL] [Abstract][Full Text] [Related]
13. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor residues required for stereospecific ligand recognition and activation.
Bocchinfuso WP; Korach KS
Mol Endocrinol; 1997 May; 11(5):587-94. PubMed ID: 9139802
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
[TBL] [Abstract][Full Text] [Related]
16. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
Guo ZR; Yi X; Xu ZB
Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
[TBL] [Abstract][Full Text] [Related]
17. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
[TBL] [Abstract][Full Text] [Related]
18. Diethylstilbestrol metabolites and analogs. Biochemical probes for differential stimulation of uterine estrogen responses.
Korach KS; Fox-Davies C; Quarmby VE; Swaisgood MH
J Biol Chem; 1985 Dec; 260(29):15420-6. PubMed ID: 4066677
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes.
Korach KS; Sarver P; Chae K; McLachlan JA; McKinney JD
Mol Pharmacol; 1988 Jan; 33(1):120-6. PubMed ID: 3122017
[TBL] [Abstract][Full Text] [Related]
20. Effects of estradiol on estrogen receptor, progesterone receptor, and tyrosinase in hamster melanoma transplanted into athymic mice.
Hitselberger MH; Schleicher RL; Beattie CW
Cancer Res; 1988 Jul; 48(13):3720-7. PubMed ID: 3132319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
